MedPath

Study on Glucose response to an nutritional beverage among adults with type 2 diabetes

Not Applicable
Completed
Conditions
Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications
Registration Number
CTRI/2022/10/046195
Lead Sponsor
Madras Diabetes Research Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
25
Inclusion Criteria

1Patients with type 2 diabetes on stable doses of oral hypoglycaemic agents (OHA) for a period of minimum 3 months and not receiving insulin

Male or Female between 30 years to 65 years of age

HbA1c between 7% to 11% both inclusive

If on anti-hypertensive, lipid-lowering, or thyroid medications or hormone therapy, has been on constant dosage for at least 3 months prior to screening visit.

Willing to give written informed consent

Willing to comply with the requirements of the protocol

Exclusion Criteria

a known history of diabetes mellitus or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related conditions

pregnant or lactating women

a major medical or surgical event requiring hospitalization within the preceding 3 months;

the presence of disease or drug(s) which influence digestion and absorption of nutrients;

the use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of nutritional beverage on 24hour glycemic response.Timepoint: 14 days continuous glucose monitoring using Abbott Free style Libre
Secondary Outcome Measures
NameTimeMethod
To assess the effect of nutritional beverage on satiety level of participants.Timepoint: 2 points (base and end of each intervention period
© Copyright 2025. All Rights Reserved by MedPath